Metformin may reduce oral cancer risk in patients with type 2 diabetes

BACKGROUND: Whether metformin use may affect the risk of oral cancer required further investigation. METHODS: The reimbursement database of the National Health Insurance in Taiwan was used. Patients with type 2 diabetes mellitus at an onset age of 25-74 years during 1999-2005 and newly treated with...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811512/
https://www.ncbi.nlm.nih.gov/pubmed/26683519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811512/
https://www.ncbi.nlm.nih.gov/pubmed/26683519

Ejemplares similares